After smoking and drinking, obesity is the major cause of all types of gastric cancer, with rapid increase in obesity, risk of stomach cancer is also increasing correspondingly. Overweight leads to gastrointestinal cancer that have three main characteristics, abnormality in insulin signaling, chronic low-grade infection, and metabolism of sex hormones. A report from IARC (International Agency for Research in Cancer) suggested that excessive body fat can lead to sixteen or more types of cancer, which makes obesity the second most prominent cause of cancer after smoking. According to the IARC and the World Cancer Research Fund (WCRF), excess adiposity is a cause or a probable risk factor for gastrointestinal malignancies, including those of the pancreas, liver, oesophagus, colorectum, stomach, and gallbladder. This report also states that the reduction in body fat can reduce the risk of gastrointestinal cancers.

To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/stomach-cancer-treatment-market/7734

Personalized medicine involves using an individual's genetic profile to guide decisions made in regard to the diagnosis, prevention, and treatment of diseases. Advancements in biomarkers and personalized medicine have transformed the treatment of cancer, which has led to the development of innovative targeted immunotherapies and personalized treatment plans for patients. This had raised the demand for customized cancer treatments, which in turn is expected to propel the growth of the Stomach Cancer Treatment market. The prominent market players are progressively implementing several initiatives such as training programs to educate clinicians, pathologists, and patients about biomarkers.

Reports Segmentation: -

By Treatment Type:
• Chemotherapy
• Radiotherapy
• Immunotherapy
• Targeted Drug Therapy
• Surgery

By End User:
• Hospitals and Clinics
• Specialized Cancer Treatment Centers
• Ambulatory Surgical Centers

Some of the prominent players operating in the Stomach Cancer Treatment Market includes: -

• Eli Lilly and Company
• Novartis International AG
• Merck & Co. Inc.
• F. Hoffman La-Roche Ltd.
• Otsuka Pharmaceutical Co. Ltd
• Bayer AG
• Celltrion Inc.
• Tahio Pharmaceutical Co. Ltd.
• Bristol-Myers Squibb Co.
• Ipsen pharma S.A.

Browse the full report now: https://growthplusreports.com/report/stomach-cancer-treatment-market/7734

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.